Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
Background: Amyotrophic Lateral Sclerosis (ALS) is a relentlessly progressive neurodegenerative condition with limited therapeutic options at present. Survival from symptom onset ranges from 3 to 5 years depending on genetic, demographic, and phenotypic factors. Despite tireless research efforts, th...
Main Authors: | Vincent Grollemund, Pierre-François Pradat, Giorgia Querin, François Delbot, Gaétan Le Chat, Jean-François Pradat-Peyre, Peter Bede |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00135/full |
Similar Items
-
Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration
by: Rangariroyashe H Chipika, et al.
Published: (2022-01-01) -
Motor imagery in amyotrophic lateral Sclerosis: An fMRI study of postural control
by: Malek Abidi, et al.
Published: (2022-01-01) -
Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas
by: Mohammed Khamaysa, et al.
Published: (2022-09-01) -
From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies
by: Serge Mignani, et al.
Published: (2020-07-01) -
Harnessing Big Data in Amyotrophic Lateral Sclerosis: Machine Learning Applications for Clinical Practice and Pharmaceutical Trials
by: Ee Ling Tan, et al.
Published: (2024-03-01)